Preparation and characterization of bFGF and BSA-loaded microspheres

被引:7
作者
Cetin, M
Capan, Y [1 ]
Vural, I
Dogan, AL
Guc, D
Hincal, AA
Wehrlé, P
Dalkara, T
机构
[1] Hacettepe Univ, Fac Pharm, Dept Pharmaceut Technol, TR-06100 Ankara, Turkey
[2] Hacettepe Univ, Inst Oncol, Dept Basic Oncol, TR-06100 Ankara, Turkey
[3] Hacettepe Univ, Fac Med, Dept Neurol, TR-06100 Ankara, Turkey
[4] Univ Louis Pasteur Strasbourg 1, Fac Pharm, Pharmaceut Technol Lab, F-67401 Illkirch Graffenstaden, France
关键词
PLGA; microspheres; BSA; bFGF; SDS-PAGE;
D O I
10.1016/S1773-2247(05)50067-4
中图分类号
R9 [药学];
学科分类号
1007 [药学];
摘要
This article describes the preparation and characterization of BSA and bFGF-loaded PLGA microspheres and assesses the effect of entrapment procedure and in vitro release conditions. In the experiments, changing the PVA concentration from 3 to 5% (w/v) in the pre-emulsion innerphase led to a change in particle size and encapsulation efficiency of BSA-loaded and bFGF-loaded PLGA microspheres from 1 to 0.7 mu m and from 73 to 65%, respectively. The in vitro release of the bFGF from PLGA microspheres was much lower than BSA-loaded PLGA microspheres. For all of the formulations, BSA and bFGF retained integrity after the microencapsulation process as evaluated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). Besides, the cell proliferation-stimulating activity of bFGF was evaluated by using BALB/c 3T3 cells and it was shown that the bioactivity of bFGF was increased by adding heparin to the release medium.
引用
收藏
页码:371 / 375
页数:5
相关论文
共 25 条
[1]
A novel in vitro delivery system for assessing the biological integrity of protein upon release from PLGA microspheres [J].
Aubert-Pouëssel, A ;
Bibby, DC ;
Venier-Julienne, MC ;
Hindré, F ;
Benoît, JP .
PHARMACEUTICAL RESEARCH, 2002, 19 (07) :1046-1051
[2]
Growth factor delivery for tissue engineering [J].
Babensee, JE ;
McIntire, LV ;
Mikos, AG .
PHARMACEUTICAL RESEARCH, 2000, 17 (05) :497-504
[3]
Protein encapsulation and release from poly(lactide-co-glycolide) microspheres: effect of the protein and polymer properties and of the co-encapsulation of surfactants [J].
Blanco, D ;
Alonso, MJ .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 1998, 45 (03) :285-294
[4]
Development and characterization of protein-loaded poly(lactide-co-glycolide) nanospheres [J].
Blanco, MD ;
Alonso, MJ .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 1997, 43 (03) :287-294
[5]
CAPAN Y, 2003, AAPS PHARMSCITECH, V4, P236
[6]
CELEBRI N, 1990, P INT S CONTROL RELE, V17, P461
[7]
CETIN M, 2003, AAPS ANN M EXP UT 26, V5
[8]
Intravenous fibroblast growth factor penetrates the blood-brain barrier and protects hippocampal neurons against ischemia-reperfusion injury [J].
Cuevas, P ;
Carceller, F ;
Munoz-Willery, I ;
Gimenez-Gallego, G .
SURGICAL NEUROLOGY, 1998, 49 (01) :77-83
[9]
The high molecular weight isoforms of basic fibroblast growth factor (FGF-2): an insight into an intracrine mechanism [J].
Delrieu, I .
FEBS LETTERS, 2000, 468 (01) :6-10
[10]
HEPARIN PROTECTS BASIC AND ACIDIC FGF FROM INACTIVATION [J].
GOSPODAROWICZ, D ;
CHENG, J .
JOURNAL OF CELLULAR PHYSIOLOGY, 1986, 128 (03) :475-484